Moore Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.7M | Buy |
120,000
+30,000
| +33% | +$5.18M | 0.26% | 61 |
|
|
2025
Q1 | $14M | Buy |
90,000
+70,000
| +350% | +$10.9M | 0.29% | 51 |
|
|
2024
Q4 | $2.75M | Sell |
20,000
-20,000
| -50% | -$2.75M | 0.03% | 223 |
|
|
2024
Q3 | $5.97M | Buy |
+40,000
| New | +$5.97M | 0.11% | 149 |
|
|
2023
Q1 | – | Sell |
-20,000
| Closed | -$2.44M | – | 466 |
|
|
2022
Q4 | $2.44M | Buy |
+20,000
| New | +$2.44M | 0.06% | 235 |
|
|
2020
Q1 | – | Sell |
-37,133
| Closed | -$5.17M | – | 161 |
|
|
2019
Q4 | $5.17M | Buy |
+37,133
| New | +$5.17M | 0.17% | 125 |
|